stockrowCytek Biosciences, Inc. (CTKB) vs VAREX IMAGING (VREX)
- Cytek Biosciences, Inc. CTKB 5.78 +7.04%
- VAREX IMAGING VREX 18.45 +0.05%
Cytek Biosciences, Inc. and VAREX IMAGING are both Medical Devices companies. VAREX IMAGING is the larger, with a market value of $783.0M against $701.9M — 1.1× the size. Cytek Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; VAREX IMAGING trades at 34.8×. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.50% against 5.31%. VAREX IMAGING has the higher net margin (2.55% vs −39.1%) and the higher return on invested capital (5.95% vs −42.1%). Across the 18 metrics below, VAREX IMAGING leads on 12 and Cytek Biosciences, Inc. on 6.
Valuation
Profitability
| Metric | CTKB | VREX | Medical Devices median |
|---|---|---|---|
| Gross margin | 54.75% | 34.32% | 57.76% |
| Operating margin | (21.13%) | 8.35% | (15.07%) |
| Net margin | (39.10%) | 2.55% | (14.45%) |
| Free cash flow margin | (6.43%) | (2.34%) | (3.88%) |
| Return on equity | (23.20%) | 4.51% | (10.35%) |
| Return on assets | (17.26%) | 2.03% | (17.26%) |
| Return on invested capital | (42.08%) | 5.95% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack